Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Study of the interference problems of dioxin-like chemicals with the bio-analytical method CALUX.

Talanta

Schroijen C, Windal I, Goeyens L, Baeyens W.
PMID: 18969556
Talanta. 2004 Aug 08;63(5):1261-8. doi: 10.1016/j.talanta.2004.05.036.

The reporter gene expression method CALUX has proven to be a very valuable screening technique for assessing toxic equivalents of dioxins and dioxin-like compounds, because it detects all AhR ligands in a variety of sample matrices. However, the exact...

Cite
Schroijen C, Windal I, Goeyens L, et al. Study of the interference problems of dioxin-like chemicals with the bio-analytical method CALUX. Talanta. 2004;63(5):1261-8doi: 10.1016/j.talanta.2004.05.036.
Schroijen, C., Windal, I., Goeyens, L., & Baeyens, W. (2004). Study of the interference problems of dioxin-like chemicals with the bio-analytical method CALUX. Talanta, 63(5), 1261-8. https://doi.org/10.1016/j.talanta.2004.05.036
Schroijen, Carmen, et al. "Study of the interference problems of dioxin-like chemicals with the bio-analytical method CALUX." Talanta vol. 63,5 (2004): 1261-8. doi: https://doi.org/10.1016/j.talanta.2004.05.036
Schroijen C, Windal I, Goeyens L, Baeyens W. Study of the interference problems of dioxin-like chemicals with the bio-analytical method CALUX. Talanta. 2004 Aug 08;63(5):1261-8. doi: 10.1016/j.talanta.2004.05.036. PMID: 18969556.
Copy Download .nbib Format: NLM
Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma.

Journal of hematopathology

Schreuder MI, van den Brand M, Hebeda KM, Groenen PJTA, van Krieken JH, Scheijen B.
PMID: 29225710
J Hematop. 2017 Sep 25;10(3):91-107. doi: 10.1007/s12308-017-0302-2. eCollection 2017 Dec.

Extranodal marginal zone lymphoma (EMZL), mostly represented by mucosa-associated lymphoid tissue (MALT) type, also referred to as MALT lymphoma, is a clinically heterogeneous entity within the group of low-grade B cell lymphomas that arises in a wide range of...

Cite
Schreuder MI, van den Brand M, Hebeda KM, et al. Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma. J Hematop. 2017;10(3):91-107doi: 10.1007/s12308-017-0302-2.
Schreuder, M. I., van den Brand, M., Hebeda, K. M., Groenen, P. J. T. A., van Krieken, J. H., & Scheijen, B. (2017). Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma. Journal of hematopathology, 10(3), 91-107. https://doi.org/10.1007/s12308-017-0302-2
Schreuder, Max I, et al. "Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma." Journal of hematopathology vol. 10,3 (2017): 91-107. doi: https://doi.org/10.1007/s12308-017-0302-2
Schreuder MI, van den Brand M, Hebeda KM, Groenen PJTA, van Krieken JH, Scheijen B. Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma. J Hematop. 2017 Sep 25;10(3):91-107. doi: 10.1007/s12308-017-0302-2. eCollection 2017 Dec. PMID: 29225710; PMCID: PMC5712330.
Copy Download .nbib Format: NLM
Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGS.

The Journal of molecular diagnostics : JMD

van den Brand M, Rijntjes J, Möbs M, Steinhilber J, van der Klift MY, Heezen KC, Kroeze LI, Reigl T, Porc J, Darzentas N, Luijks JACW, Scheijen B, Davi F, ElDaly H, Liu H, Anagnostopoulos I, Hummel M, Fend F, Langerak AW, Groenen PJTA.
PMID: 34186174
J Mol Diagn. 2021 Sep;23(9):1105-1115. doi: 10.1016/j.jmoldx.2021.06.005. Epub 2021 Jun 26.

Ig gene (IG) clonality analysis has an important role in the distinction of benign and malignant B-cell lymphoid proliferations and is mostly performed with the conventional EuroClonality/BIOMED-2 multiplex PCR protocol and GeneScan fragment size analysis. Recently, the EuroClonality-NGS Working...

Cite
van den Brand M, Rijntjes J, Möbs M, et al. Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGS. J Mol Diagn. 2021;23(9):1105-1115doi: 10.1016/j.jmoldx.2021.06.005.
van den Brand, M., Rijntjes, J., Möbs, M., Steinhilber, J., van der Klift, M. Y., Heezen, K. C., Kroeze, L. I., Reigl, T., Porc, J., Darzentas, N., Luijks, J. A. C. W., Scheijen, B., Davi, F., ElDaly, H., Liu, H., Anagnostopoulos, I., Hummel, M., Fend, F., Langerak, A. W., Groenen, P. J. T. A. (2021). Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGS. The Journal of molecular diagnostics : JMD, 23(9), 1105-1115. https://doi.org/10.1016/j.jmoldx.2021.06.005
van den Brand, Michiel, et al. "Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGS." The Journal of molecular diagnostics : JMD vol. 23,9 (2021): 1105-1115. doi: https://doi.org/10.1016/j.jmoldx.2021.06.005
van den Brand M, Rijntjes J, Möbs M, Steinhilber J, van der Klift MY, Heezen KC, Kroeze LI, Reigl T, Porc J, Darzentas N, Luijks JACW, Scheijen B, Davi F, ElDaly H, Liu H, Anagnostopoulos I, Hummel M, Fend F, Langerak AW, Groenen PJTA. Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGS. J Mol Diagn. 2021 Sep;23(9):1105-1115. doi: 10.1016/j.jmoldx.2021.06.005. Epub 2021 Jun 26. PMID: 34186174.
Copy Download .nbib Format: NLM
Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

van Bladel DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, Haacke DLCM, Luijks JACW, Hebeda KM, van Krieken JHJM, Groenen PJTA, Scheijen B.
PMID: 34862451
Mod Pathol. 2021 Dec 03; doi: 10.1038/s41379-021-00983-8. Epub 2021 Dec 03.

Clonality analysis in classic Hodgkin lymphoma (cHL) is of added value for correctly diagnosing patients with atypical presentation or histology reminiscent of T cell lymphoma, and for establishing the clonal relationship in patients with recurrent disease. However, such analysis...

Cite
van Bladel DAG, van den Brand M, Rijntjes J, et al. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Mod Pathol. 2021;doi: 10.1038/s41379-021-00983-8.
van Bladel, D. A. G., van den Brand, M., Rijntjes, J., Pamidimarri Naga, S., Haacke, D. L. C. M., Luijks, J. A. C. W., Hebeda, K. M., van Krieken, J. H. J. M., Groenen, P. J. T. A., & Scheijen, B. (2021). Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, . https://doi.org/10.1038/s41379-021-00983-8
van Bladel, Diede A G, et al. "Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. (2021). doi: https://doi.org/10.1038/s41379-021-00983-8
van Bladel DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, Haacke DLCM, Luijks JACW, Hebeda KM, van Krieken JHJM, Groenen PJTA, Scheijen B. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Mod Pathol. 2021 Dec 03; doi: 10.1038/s41379-021-00983-8. Epub 2021 Dec 03. PMID: 34862451.
Copy Download .nbib Format: NLM
[Optical rangefinder].

Nederlands tijdschrift voor tandheelkunde

van de Poel AC, Schrijer FE.
PMID: 5285582
Ned Tijdschr Tandheelkd. 1971 Aug-Sep;78(8):318-9.

No abstract available.

Cite
van de Poel AC, Schrijer FE. Een lichtvizier. [Optical rangefinder]. Ned Tijdschr Tandheelkd. 1971;78(8):318-9
van de Poel, A. C., & Schrijer, F. E. (1971). Een lichtvizier. [Optical rangefinder]. Nederlands tijdschrift voor tandheelkunde, 78(8), 318-9.
van de Poel, A C, and Schrijer, F E. "Een lichtvizier." [Optical rangefinder]. Nederlands tijdschrift voor tandheelkunde vol. 78,8 (1971): 318-9.
van de Poel AC, Schrijer FE. Een lichtvizier. [Optical rangefinder]. Ned Tijdschr Tandheelkd. 1971 Aug-Sep;78(8):318-9. Dutch. PMID: 5285582.
Copy Download .nbib Format: NLM
Noninvasive treatment alternative for intractable startle epilepsy.

Epilepsy & behavior case reports

Klinkenberg S, Ubbink S, Vles J, de Louw A, van Hall MD, Scheijen D, Brokx J.
PMID: 25667869
Epilepsy Behav Case Rep. 2014 Apr 01;2:49-53. doi: 10.1016/j.ebcr.2014.02.002. eCollection 2014.

We describe a treatment alternative for intractable, startle-provoked, epileptic seizures in four children aged between 8 and 14. Three of the four children had symptomatic localization-related epilepsy. They all suffered from intractable epilepsy precipitated by sudden sounds. The fact...

Cite
Klinkenberg S, Ubbink S, Vles J, et al. Noninvasive treatment alternative for intractable startle epilepsy. Epilepsy Behav Case Rep. 2014;2:49-53doi: 10.1016/j.ebcr.2014.02.002.
Klinkenberg, S., Ubbink, S., Vles, J., de Louw, A., van Hall, M. D., Scheijen, D., & Brokx, J. (2014). Noninvasive treatment alternative for intractable startle epilepsy. Epilepsy & behavior case reports, 249-53. https://doi.org/10.1016/j.ebcr.2014.02.002
Klinkenberg, Sylvia, et al. "Noninvasive treatment alternative for intractable startle epilepsy." Epilepsy & behavior case reports vol. 2 (2014): 49-53. doi: https://doi.org/10.1016/j.ebcr.2014.02.002
Klinkenberg S, Ubbink S, Vles J, de Louw A, van Hall MD, Scheijen D, Brokx J. Noninvasive treatment alternative for intractable startle epilepsy. Epilepsy Behav Case Rep. 2014 Apr 01;2:49-53. doi: 10.1016/j.ebcr.2014.02.002. eCollection 2014. PMID: 25667869; PMCID: PMC4308030.
Copy Download .nbib Format: NLM
Correction to: Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

van Bladel DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, Haacke DLCM, Luijks JACW, Hebeda KM, van Krieken JHJM, Groenen PJTA, Scheijen B.
PMID: 34912039
Mod Pathol. 2021 Dec 15; doi: 10.1038/s41379-021-00986-5. Epub 2021 Dec 15.

No abstract available.

Cite
van Bladel DAG, van den Brand M, Rijntjes J, et al. Correction to: Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Mod Pathol. 2021;doi: 10.1038/s41379-021-00986-5.
van Bladel, D. A. G., van den Brand, M., Rijntjes, J., Pamidimarri Naga, S., Haacke, D. L. C. M., Luijks, J. A. C. W., Hebeda, K. M., van Krieken, J. H. J. M., Groenen, P. J. T. A., & Scheijen, B. (2021). Correction to: Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, . https://doi.org/10.1038/s41379-021-00986-5
van Bladel, Diede A G, et al. "Correction to: Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. (2021). doi: https://doi.org/10.1038/s41379-021-00986-5
van Bladel DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, Haacke DLCM, Luijks JACW, Hebeda KM, van Krieken JHJM, Groenen PJTA, Scheijen B. Correction to: Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Mod Pathol. 2021 Dec 15; doi: 10.1038/s41379-021-00986-5. Epub 2021 Dec 15. PMID: 34912039.
Copy Download .nbib Format: NLM
Reconstruction of Chest Wall Defects Using a Technique Involving Mesh, Titanium Plates, and a Pedunculated Muscle Flap.

The Korean journal of thoracic and cardiovascular surgery

Koole D, Bemelman M, Schijen J, de Fijter M, van der Niet J.
PMID: 30402389
Korean J Thorac Cardiovasc Surg. 2018 Oct;51(5):308-311. doi: 10.5090/kjtcs.2018.51.5.308. Epub 2018 Oct 05.

We herein present a new surgical reconstruction technique for large chest wall defects after resection of advanced chest wall tumors.

Cite
Koole D, Bemelman M, Schijen J, et al. Reconstruction of Chest Wall Defects Using a Technique Involving Mesh, Titanium Plates, and a Pedunculated Muscle Flap. Korean J Thorac Cardiovasc Surg. 2018;51(5):308-311doi: 10.5090/kjtcs.2018.51.5.308.
Koole, D., Bemelman, M., Schijen, J., de Fijter, M., & van der Niet, J. (2018). Reconstruction of Chest Wall Defects Using a Technique Involving Mesh, Titanium Plates, and a Pedunculated Muscle Flap. The Korean journal of thoracic and cardiovascular surgery, 51(5), 308-311. https://doi.org/10.5090/kjtcs.2018.51.5.308
Koole, Dave, et al. "Reconstruction of Chest Wall Defects Using a Technique Involving Mesh, Titanium Plates, and a Pedunculated Muscle Flap." The Korean journal of thoracic and cardiovascular surgery vol. 51,5 (2018): 308-311. doi: https://doi.org/10.5090/kjtcs.2018.51.5.308
Koole D, Bemelman M, Schijen J, de Fijter M, van der Niet J. Reconstruction of Chest Wall Defects Using a Technique Involving Mesh, Titanium Plates, and a Pedunculated Muscle Flap. Korean J Thorac Cardiovasc Surg. 2018 Oct;51(5):308-311. doi: 10.5090/kjtcs.2018.51.5.308. Epub 2018 Oct 05. PMID: 30402389; PMCID: PMC6200169.
Copy Download .nbib Format: NLM
Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

van Bladel DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, Haacke DLCM, Luijks JACW, Hebeda KM, van Krieken JHJM, Groenen PJTA, Scheijen B.
PMID: 34862451
Mod Pathol. 2021 Dec 03; doi: 10.1038/s41379-021-00983-8. Epub 2021 Dec 03.

Clonality analysis in classic Hodgkin lymphoma (cHL) is of added value for correctly diagnosing patients with atypical presentation or histology reminiscent of T cell lymphoma, and for establishing the clonal relationship in patients with recurrent disease. However, such analysis...

Cite
van Bladel DAG, van den Brand M, Rijntjes J, et al. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Mod Pathol. 2021;doi: 10.1038/s41379-021-00983-8.
van Bladel, D. A. G., van den Brand, M., Rijntjes, J., Pamidimarri Naga, S., Haacke, D. L. C. M., Luijks, J. A. C. W., Hebeda, K. M., van Krieken, J. H. J. M., Groenen, P. J. T. A., & Scheijen, B. (2021). Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, . https://doi.org/10.1038/s41379-021-00983-8
van Bladel, Diede A G, et al. "Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. (2021). doi: https://doi.org/10.1038/s41379-021-00983-8
van Bladel DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, Haacke DLCM, Luijks JACW, Hebeda KM, van Krieken JHJM, Groenen PJTA, Scheijen B. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Mod Pathol. 2021 Dec 03; doi: 10.1038/s41379-021-00983-8. Epub 2021 Dec 03. PMID: 34862451.
Copy Download .nbib Format: NLM
Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma.

Clinical chemistry

Langerhorst P, Brinkman AB, VanDuijn MM, Wessels HJCT, Groenen PJTA, Joosten I, van Gool AJ, Gloerich J, Scheijen B, Jacobs JFM.
PMID: 33709101
Clin Chem. 2021 Jun 01;67(6):867-875. doi: 10.1093/clinchem/hvab017.

BACKGROUND: Due to improved treatment, more patients with multiple myeloma (MM) reach a state of minimal residual disease (MRD). Different strategies for MM MRD monitoring include flow cytometry, allele-specific oligonucleotide-quantitative PCR, next-generation sequencing, and mass spectrometry (MS). The last...

Cite
Langerhorst P, Brinkman AB, VanDuijn MM, et al. Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma. Clin Chem. 2021;67(6):867-875doi: 10.1093/clinchem/hvab017.
Langerhorst, P., Brinkman, A. B., VanDuijn, M. M., Wessels, H. J. C. T., Groenen, P. J. T. A., Joosten, I., van Gool, A. J., Gloerich, J., Scheijen, B., & Jacobs, J. F. M. (2021). Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma. Clinical chemistry, 67(6), 867-875. https://doi.org/10.1093/clinchem/hvab017
Langerhorst, Pieter, et al. "Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma." Clinical chemistry vol. 67,6 (2021): 867-875. doi: https://doi.org/10.1093/clinchem/hvab017
Langerhorst P, Brinkman AB, VanDuijn MM, Wessels HJCT, Groenen PJTA, Joosten I, van Gool AJ, Gloerich J, Scheijen B, Jacobs JFM. Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma. Clin Chem. 2021 Jun 01;67(6):867-875. doi: 10.1093/clinchem/hvab017. PMID: 33709101.
Copy Download .nbib Format: NLM
Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

van Bladel DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, Haacke DLCM, Luijks JACW, Hebeda KM, van Krieken JHJM, Groenen PJTA, Scheijen B.
PMID: 34862451
Mod Pathol. 2021 Dec 03; doi: 10.1038/s41379-021-00983-8. Epub 2021 Dec 03.

Clonality analysis in classic Hodgkin lymphoma (cHL) is of added value for correctly diagnosing patients with atypical presentation or histology reminiscent of T cell lymphoma, and for establishing the clonal relationship in patients with recurrent disease. However, such analysis...

Cite
van Bladel DAG, van den Brand M, Rijntjes J, et al. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Mod Pathol. 2021;doi: 10.1038/s41379-021-00983-8.
van Bladel, D. A. G., van den Brand, M., Rijntjes, J., Pamidimarri Naga, S., Haacke, D. L. C. M., Luijks, J. A. C. W., Hebeda, K. M., van Krieken, J. H. J. M., Groenen, P. J. T. A., & Scheijen, B. (2021). Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, . https://doi.org/10.1038/s41379-021-00983-8
van Bladel, Diede A G, et al. "Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. (2021). doi: https://doi.org/10.1038/s41379-021-00983-8
van Bladel DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, Haacke DLCM, Luijks JACW, Hebeda KM, van Krieken JHJM, Groenen PJTA, Scheijen B. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Mod Pathol. 2021 Dec 03; doi: 10.1038/s41379-021-00983-8. Epub 2021 Dec 03. PMID: 34862451.
Copy Download .nbib Format: NLM
Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance.

Cancers

Berendsen MR, Stevens WBC, van den Brand M, van Krieken JH, Scheijen B.
PMID: 33260693
Cancers (Basel). 2020 Nov 28;12(12). doi: 10.3390/cancers12123553.

The majority of patients with diffuse large B-cell lymphoma (DLBCL) can be treated successfully with a combination of chemotherapy and the monoclonal anti-CD20 antibody rituximab. Nonetheless, approximately one-third of the patients with DLBCL still experience relapse or refractory (R/R)...

Cite
Berendsen MR, Stevens WBC, van den Brand M, et al. Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance. Cancers (Basel). 2020;12(12)doi: 10.3390/cancers12123553.
Berendsen, M. R., Stevens, W. B. C., van den Brand, M., van Krieken, J. H., & Scheijen, B. (2020). Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance. Cancers, 12(12), . https://doi.org/10.3390/cancers12123553
Berendsen, Madeleine R, et al. "Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance." Cancers vol. 12,12 (2020). doi: https://doi.org/10.3390/cancers12123553
Berendsen MR, Stevens WBC, van den Brand M, van Krieken JH, Scheijen B. Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance. Cancers (Basel). 2020 Nov 28;12(12). doi: 10.3390/cancers12123553. PMID: 33260693; PMCID: PMC7760867.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries